A Randomized, Parallel, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986036 in Healthy Japanese and Non-Japanese Subjects

Trial Profile

A Randomized, Parallel, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986036 in Healthy Japanese and Non-Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs BMS 986036 (Primary)
  • Indications Fibrosis; Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 05 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 19 Sep 2017 Planned End Date changed from 12 Sep 2017 to 22 Sep 2017.
    • 19 Sep 2017 Planned primary completion date changed from 11 Sep 2017 to 22 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top